-
Treatment Patterns and Healthcare Resource Utilization Among Patients With Immune Thrombocytopenia: A Real-World Survey
Sep 9, 2025, 16:22 PM -
Quantification of Life-Cycle Value Using Early Modeling to Support RD and Strategy Decisions: A Case Study of a Polymeric Heart Valve
Sep 9, 2025, 16:22 PM -
Inpatient Cost of Managing Adverse Events (AEs) Associated With Immune Checkpoint Inhibitors (ICI) Approved for Advanced or Metastatic Cancers in the UK
Sep 9, 2025, 16:22 PM -
Clinical Outcomes and Economic Burden of Acute Lower Respiratory Tract Infection-Related Hospitalizations Among Adults in the United States Post COVID-19 Pandemic
Sep 9, 2025, 16:22 PM -
Economic Evaluation Of Cefiderocol for the Treatment of Carbapenem-Resistant Acinetobacter Baumannii in Italy Using Real-World Evidence
Sep 9, 2025, 16:22 PM -
What Does the New ILAP Refresh Mean for Pharmaceutical Development and Patient Access in the UK?
Sep 9, 2025, 16:22 PM -
Empirical Comparison of Four Approaches for Generating Confidence Intervals Around Weighted Trial-Level Correlation
Sep 9, 2025, 16:22 PM -
A Decade of Change in Turkish Healthcare Utilization: Hospital Admission Trends 2015-2024
Sep 9, 2025, 16:22 PM -
Accounting for Bereavement in NICE Pediatric Health Technology Appraisals: A Review of the Inclusion of Caregiver Health Utilities After the Death of a Child
Sep 9, 2025, 16:22 PM -
Quality of Systematic Reviews With Network Meta-Analyses on JAK Inhibitors in the Treatment of Rheumatoid Arthritis: Application of the AMSTAR 2 Scale
Sep 9, 2025, 16:22 PM -
Evaluation and Validation of the Hypoparathyroidism Daily Diary of Symptom Experience (HPT-DD-SE) and the Hypoparathyroidism Life Impact Questionnaire (HPT-LIQ)
Sep 9, 2025, 16:22 PM -
Perspectives on Progress: A Qualitative Study of HIV Prevention Efforts in the Czech Republic
Sep 9, 2025, 16:22 PM -
How Do National Systems Take the JCA Into Account Navigating Specificities to Achieve Accelerated Patient Access?
Sep 9, 2025, 16:22 PM -
Assessing Time Tradeoff Utilities in Health States of Organic Hypogonadotropic Hypogonadism: A Pilot Study in Brazil
Sep 9, 2025, 16:22 PM -
Real-World Utilization Patterns of Corticosteroids in Ulcerative Colitis: Prevalence of Excessive Use in Routine Clinical Practice
Sep 9, 2025, 16:22 PM -
Innovative Approaches to Real-World Evidence Generation: The Role of Italian Community Pharmacies
Sep 9, 2025, 16:22 PM -
Real-World–Based Cost-Effectiveness of Lipid-Lowering Therapies for ASCVD Patients With High CV Risk in Taiwan
Sep 9, 2025, 16:22 PM -
Health-Related Quality of Life Impacts of Living With Primary Lateral Sclerosis (PLS): The Development of a Conceptual Model
Sep 9, 2025, 16:22 PM -
A Cost-Minimization and Budget Impact Analysis of NT-proBNP Screening for Systematic Sclerosis-Related Pulmonary Arterial Hypertension in an Australian Healthcare Setting
Sep 9, 2025, 16:22 PM -
From Admission to Discharge: Understanding the Transplant Patient Journey With German Statutory Health Insurance Claims Data
Sep 9, 2025, 16:22 PM
